髓外肿瘤治疗:并发症与长期结果
该研究回顾1991至2024年605例硬膜内髓外肿瘤患者中500例接受的570次手术,分析切除率、永久并发症及无复发生存。完全切除率87.4%,永久手术并发症7.1%,首次手术4.8%而复发肿瘤18.4%(p<0.0001);完全切除后5年与10年无复发生存率分别为80.5%与77%。
要点
- 完全切除是获得良好长期结果的关键,首次手术尤为重要。
- 复发肿瘤永久并发症显著高于首次手术(18.4% vs 4.8%)。
- 年手术量>100例的外科医生无复发生存率更高。
核心结论
- 完全切除髓外肿瘤可获得良好的手术并发症率和10年无复发生存率。
- 蛛网膜粘连(如复发肿瘤及部分错构瘤)降低完全切除率、升高并发症率并恶化长期结果。
- 首次手术实现完全切除尤为重要。
研究设计与样本
- 回顾性队列研究,1991至2024年间2081例椎管内肿瘤患者中识别605例硬膜内髓外肿瘤,其中500例接受570次手术。
- 采用多元回归分析影响切除率和并发症率的因素,短期结果按神经评分系统分析,长期结果用Kaplan-Meier统计计算无复发生存率。
- 术后通过门诊和问卷随访,最长34年(平均43.3±64个月)。
主要发现
- 手术患者平均年龄49.8±18岁,平均病史21.2±42个月。
- 总体87.4%肿瘤完全切除,11.2%部分切除,1.4%活检。
- 术后暂时性恶化见于15.1%的手术,永久手术并发症7.1%。
- 永久并发症率首次手术为4.8%,复发肿瘤为18.4%(p<0.0001)。
- 完全切除后5年和10年无复发生存率分别为80.5%和77%,部分切除降至40.0%和36.4%(p<0.0001)。
关键数值与推荐
- 神经鞘瘤、脑膜瘤、终丝室管膜瘤和错构瘤占全部病理的89.8%。
- 神经鞘瘤切除率、永久并发症及无复发生存结果最佳;室管膜瘤和错构瘤并发症率最高。
- 除脑膜瘤(10年无复发生存率73.3%)外,各组织学类型完全切除后10年无复发生存率约90%。
- 年手术量>100例的外科医生在各术后时间点无复发生存率均显著更高。
临床怎么用
- 首次手术应力争完全切除髓外肿瘤以降低复发和永久并发症。
- 对复发肿瘤及存在蛛网膜粘连者应充分评估手术风险。
- 脊髓病理亚专科化及高手术量有助于改善长期结果。
局限性
- 单中心回顾性设计可能引入选择偏倚。
- 长期随访依赖门诊和问卷,存在失访可能。
- 复发肿瘤与首次手术的并发症差异可能受粘连等因素混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Surgery on extramedullary tumors has a place among the most gratifying operations in neurosurgery. However, little data exist on permanent morbidity and long-term results. This paper provides these data and analyzes which factors influence them and how they can be managed. METHODS: Among 2081 patients with tumors of the spinal canal presenting between 1991 and 2024, 605 patients were identified with intradural extramedullary tumors, of whom 500 patients underwent 570 operations. Multiple regression was used to identify factors influencing resection and morbidity rates. Short-term results were analyzed according to a neurological scoring system for individual symptoms, while long-term results were determined calculating recurrence-free outcome rates with Kaplan-Meier statistics. RESULTS: The mean age for operated patients was 49.8 ± 18 years, presenting after a mean history of 21.2 ± 42 months. They were followed up by outpatient visits and questionnaires for up to 34 years (mean 43.3 ± 64 months). Overall, 87.4% of tumors were resected completely, while 11.2% underwent partial resection and 1.4% biopsy. Transient postoperative deteriorations were observed in 15.1% of surgeries. Permanent surgical morbidity occurred in 7.1%, that is, 4.8% for first surgeries and 18.4% for recurrent tumors (p < 0.0001). With complete resection, recurrence-free outcome rates of 80.5% and 77% after 5 and 10 years, respectively, were obtained, while partial resection reduced these rates to 40.0% and 36.4% after 5 and 10 years, respectively (p < 0.0001). Surgeons with > 100 operations achieved significantly higher recurrence-free outcome rates compared to surgeons with less experience at each postoperative time point. Schwannomas, meningiomas, ependymomas of the filum terminale, and hamartomas represented 89.8% of all pathologies and were analyzed separately. The best results for resection rates, permanent morbidity, and recurrence-free outcomes were observed for schwannomas. The highest morbidity rates were determined for ependymomas and hamartomas. Complete resection resulted in recurrence-free outcome rates of around 90% after 10 years for each histological group with the exception of meningiomas (73.3%). CONCLUSIONS: Whenever an extramedullary tumor is completely resected, rates for surgical morbidity and 10-year recurrence-free outcomes are favorable. In contrast, with arachnoid adhesions, as in recurrent tumors and some hamartomas, complete resection rates decline, morbidity rates rise, and long-term results become less satisfactory. This emphasizes the importance of achieving complete resection, particularly in the first operation. Surgeons dedicated to spinal cord pathologies can expect to achieve superior long-term results.
引用
- Klekamp J. Treatment of extramedullary tumors: morbidity and long-term results. J Neurosurg Spine. 2026. PMID: 41962167. doi:10.3171/2025.11.SPINE251323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。